Ausbruch steht an! - 500 Beiträge pro Seite
eröffnet am 29.03.05 11:35:20 von
neuester Beitrag 02.04.05 00:16:35 von
neuester Beitrag 02.04.05 00:16:35 von
Beiträge: 9
ID: 969.772
ID: 969.772
Aufrufe heute: 0
Gesamt: 1.310
Gesamt: 1.310
Aktive User: 0
ISIN: US8172093077
Nach der Telefonkonf. wird es endgültig abgehen...
Bei Order an strenges Limit denken!
und wie hoch wird der ausbruch erfolgen???
invest2002
invest2002
ich denke an Kurse so um die 0,5 - 0,55 Euro...
Zeitrahmen: 20 - 30 Tage
Zeitrahmen: 20 - 30 Tage
hallo mal,bin neu hier. Meine Frage, was macht dich da so sicher? hab mir auch welche unter den Nagel gerissen,denke dass sie so bis 0,30-0,35 läuft, aber erst über einen längeren Zeitraum
Sicher? Sicher macht mich gar nix... Aber die Chance ist riesig. Aktien mit diesem "Chartbild" machen oftmals riesige Sprünge.
Hatte damit schon oft Glück! Siehe Abacho. Da ging es auch richtig zur Sache als der Chart so aussah.
Und die Telefonkonf. wird der Anfang denke ich! Gute Zahlen werden auch folgen...
Hatte damit schon oft Glück! Siehe Abacho. Da ging es auch richtig zur Sache als der Chart so aussah.
Und die Telefonkonf. wird der Anfang denke ich! Gute Zahlen werden auch folgen...
ich beobachte die sache auch, sieht ja nicht so schlecht aus
hallo mal, wie schaut`s aus? wo geht der Trend hin? hat jemand eina Ahnung?
Jetzt siehts wohl mega-mies aus. Na ja, allszuviel waren die shares eh nicht mehr wert, deshalb verkauf ich auch nicht. Wer wisß - Wunder solls ja geben...
Allen " Mitleidenden" viel Glück mit unserem zukünftigen OTC-Wert SNTK!
Das also hatte ich leider befürchtet:
In announcing this letter from NASDAQ, Senetek said it will appeal. Once a hearing is requested, no action is taken
until a panel has made a decision, which usually takes some number of months. Senetek is required to trade at 58
cents a share to meet NASDAQ`s market cap requirement.
Senetek PLC Receives Delisting Letter From Nasdaq
PR Newswire -- August 18, 2004
NAPA, Calif., Aug. 18 /PRNewswire-FirstCall/ -- Senetek PLC
(Nasdaq: SNTK), www.senetekplc.com, a healthcare technologies company focused
on developing and co-marketing products for the anti-aging markets worldwide,
announced that on August 17 the Listing Qualifications Division of The Nasdaq
Stock Market, Inc. notified Senetek of its decision to delist Senetek`s
American Depositary Shares from the Nasdaq SmallCap Market due to non-
compliance with the minimum continued listing standards set forth in
Marketplace Rule 4310(c)(2)(B), which requires market value of listed
securities of $35 million, or net income from continuing operation of at least
$500,000 in the most recently completed fiscal year or two of the last three
most recently completed fiscal years, or shareholders` equity of $2.5 million.
The Nasdaq Staff`s decision followed a submission in which Senetek noted
that the weighted average price of its shares for the 12 months ended June 30,
2004 was $0.87, well above the $0.58 per share needed to maintain Nasdaq`s
$35 million market capitalization standard, and sought Nasdaq`s assistance in
identifying the source of recent downward pressure on its share price despite
favorable earnings and business development announcements. Senetek also had
asked Nasdaq to defer action until 2004 year end to permit Senetek to
demonstrate compliance with Nasdaq`s alternate $500,000 income from continuing
operations standard for 2004, noting Senetek`s $245,000 of income from
continuing operations for the first six months of 2004. Senetek informed
Nasdaq, however, that while Senetek believes that it could have arranged
equity financing sufficient to achieve Nasdaq`s $2.5 million shareholders`
equity standard and thereby maintain its listing, its Board of Directors had
determined that at its shares` currently depressed price such a financing
would not be in shareholders` best interest.
Nasdaq`s letter advises that the Company may appeal the Staff`s
determination to a Listing Qualifications Panel of Nasdaq, and that a hearing
request will stay the delisting of the Company`s securities pending the
Panel`s decision. Senetek intends to formally appeal the Nasdaq Staff`s
delisting decision.
Senetek PLC Investor Relations Contact:
1-707-226-3900, ext. 102
Email: Pknopick@eandecommunications.com
Safe Harbor Statement
This news release contains statements that may be considered " forward-
looking statements" within the meaning of the Private Securities Litigation
Reform Act, including those that might imply an expectation of a successful
appeal of the Nasdaq Staff`s delisting decision and achievement of at least
$500,000 of income from continuing operations for full year 2004. Forward-
looking statements by their nature involve substantial uncertainty, and actual
results may differ materially from those that might be implied by such
statements. Important factors identified by the Company that it believes
could result in such material differences are described in the Company`s
Annual Report on Form 10-K for the year 2003. However, the Company
necessarily can give no assurance that it has identified all of the factors
that may result in actual results materially differing from those that might
be expressed or implied in any particular forward-looking statement, and the
Company assumes no obligation to correct or update any forward-looking
statements which may prove to be inaccurate, whether as a result of new
information, future events or otherwise.
SOURCE Senetek PLC
-0- 08/18/2004
/CONTACT: Senetek PLC Investor Relations, +1-707-226-3900 ext. 102,
Pknopick@eandecommunications.com/
/Web site: http://www.senetekplc.com/
(SNTK)
Allen " Mitleidenden" viel Glück mit unserem zukünftigen OTC-Wert SNTK!
Das also hatte ich leider befürchtet:
In announcing this letter from NASDAQ, Senetek said it will appeal. Once a hearing is requested, no action is taken
until a panel has made a decision, which usually takes some number of months. Senetek is required to trade at 58
cents a share to meet NASDAQ`s market cap requirement.
Senetek PLC Receives Delisting Letter From Nasdaq
PR Newswire -- August 18, 2004
NAPA, Calif., Aug. 18 /PRNewswire-FirstCall/ -- Senetek PLC
(Nasdaq: SNTK), www.senetekplc.com, a healthcare technologies company focused
on developing and co-marketing products for the anti-aging markets worldwide,
announced that on August 17 the Listing Qualifications Division of The Nasdaq
Stock Market, Inc. notified Senetek of its decision to delist Senetek`s
American Depositary Shares from the Nasdaq SmallCap Market due to non-
compliance with the minimum continued listing standards set forth in
Marketplace Rule 4310(c)(2)(B), which requires market value of listed
securities of $35 million, or net income from continuing operation of at least
$500,000 in the most recently completed fiscal year or two of the last three
most recently completed fiscal years, or shareholders` equity of $2.5 million.
The Nasdaq Staff`s decision followed a submission in which Senetek noted
that the weighted average price of its shares for the 12 months ended June 30,
2004 was $0.87, well above the $0.58 per share needed to maintain Nasdaq`s
$35 million market capitalization standard, and sought Nasdaq`s assistance in
identifying the source of recent downward pressure on its share price despite
favorable earnings and business development announcements. Senetek also had
asked Nasdaq to defer action until 2004 year end to permit Senetek to
demonstrate compliance with Nasdaq`s alternate $500,000 income from continuing
operations standard for 2004, noting Senetek`s $245,000 of income from
continuing operations for the first six months of 2004. Senetek informed
Nasdaq, however, that while Senetek believes that it could have arranged
equity financing sufficient to achieve Nasdaq`s $2.5 million shareholders`
equity standard and thereby maintain its listing, its Board of Directors had
determined that at its shares` currently depressed price such a financing
would not be in shareholders` best interest.
Nasdaq`s letter advises that the Company may appeal the Staff`s
determination to a Listing Qualifications Panel of Nasdaq, and that a hearing
request will stay the delisting of the Company`s securities pending the
Panel`s decision. Senetek intends to formally appeal the Nasdaq Staff`s
delisting decision.
Senetek PLC Investor Relations Contact:
1-707-226-3900, ext. 102
Email: Pknopick@eandecommunications.com
Safe Harbor Statement
This news release contains statements that may be considered " forward-
looking statements" within the meaning of the Private Securities Litigation
Reform Act, including those that might imply an expectation of a successful
appeal of the Nasdaq Staff`s delisting decision and achievement of at least
$500,000 of income from continuing operations for full year 2004. Forward-
looking statements by their nature involve substantial uncertainty, and actual
results may differ materially from those that might be implied by such
statements. Important factors identified by the Company that it believes
could result in such material differences are described in the Company`s
Annual Report on Form 10-K for the year 2003. However, the Company
necessarily can give no assurance that it has identified all of the factors
that may result in actual results materially differing from those that might
be expressed or implied in any particular forward-looking statement, and the
Company assumes no obligation to correct or update any forward-looking
statements which may prove to be inaccurate, whether as a result of new
information, future events or otherwise.
SOURCE Senetek PLC
-0- 08/18/2004
/CONTACT: Senetek PLC Investor Relations, +1-707-226-3900 ext. 102,
Pknopick@eandecommunications.com/
/Web site: http://www.senetekplc.com/
(SNTK)
kommt langsam wieder in fahrt, mal schauen wie die nächste Woche wird ???
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Investoren beobachten auch:
Wertpapier | Perf. % |
---|---|
-0,08 | |
+0,24 | |
-0,46 | |
-0,15 | |
-0,24 | |
-0,34 | |
-0,61 | |
-1,18 | |
-0,67 | |
-0,69 |
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
96 | ||
46 | ||
45 | ||
33 | ||
32 | ||
27 | ||
21 | ||
19 | ||
19 | ||
18 |